Here's why these 4 ASX shares are getting crushed today

The S&P/ASX 200 (Index: ^AXJO) (ASX:XJO) might be rallying today but here are four shares that are getting crushed.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Following the US Federal Reserve's decision to keep US interest rates on hold and an overnight rally in commodity prices, the S&P/ASX 200 (Index: ^AXJO) (ASX:XJO) is enjoying a solid day of gains with the main index rallying 1.2%.

Not all shares are taking part in today's rally, however, and these four companies are deep in the red:

ResMed Inc. (CHESS) (ASX: RMD)

ResMed shares have lost more than 4% today despite the absence of any specific company news being released. It appears investors may be concerned about the impact of the recent surge in the Australian dollar which will negatively impact the value of its ASX scrip. Investors may also be weary of further competition in the sector with the likes of Somnomed Limited (ASX: SOM) and Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) both delivering healthy growth in their most recent earnings results.

Magellan Financial Group Ltd (ASX: MFG)

Shares of Magellan are down by more than 2.2% today as investors digest the potential negative impact on its earnings from a higher Australian dollar. Despite this, Magellan still looks like a good long-term winner thanks to its superior track record of delivering out-performance and strong relationships with institutional investors.

Ramsay Health Care Limited (ASX:RHC)

The shares of the private hospital operator have been under pressure over the past seven trading days and today's 1% fall takes its seven-day loss to more than 8%. Ramsay is the market leader in France and it appears most of the recent share price decline can be attributed to the French Government's decision to cut its tariffs for private hospitals by more than anticipated. Despite this, the company has assured investors this would not impact the company's earnings guidance which was recently upgraded following the release of its first half earnings in February.

Retail Food Group Limited (ASX: RFG)

Shares of Retail Food Group started the day on the back foot and at one point had fallen more than 5.6%. The shares have since stabilised but were still trading down by more than 4.5% at the time of writing. The obvious reason for the fall is that the shares are trading ex-dividend today. The company will pay investors a fully-franked dividend of 13 cents a share – an increase of 13% from the previous corresponding period.

Motley Fool contributor Christopher Georges owns shares of Retail Food Group. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia owns shares of Retail Food Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Polynovo shares fall despite yesterday's upbeat update. Here's what investors are watching

Polynovo shares slide after a solid update as investors wait for clearer growth signals.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

Check out this CSL share price forecast for 2026. It's hard to believe!

RBC Capital Markets thinks CSL is a bargain at current levels.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Good news out of China has this drug company's shares higher

A major new market will open up following this approval.

Read more »

woman in lab coat conducting testing.
Healthcare Shares

This rising ASX 200 stock isn't done yet – or is it?

Inching closer to FDA approval, the share price is falling. Analysts still see 21% to 106% upside.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Mesoblast just cleared a key FDA hurdle. So why are investors exiting?

Mesoblast shares slide to a 2-month low despite positive FDA feedback on its lead cell therapy product.

Read more »

Man leaps as he runs along the street.
Healthcare Shares

ASX 300 stock jumps 6% on strong half-year results and cash flow surge

Let's see how this medical device company performed during the first half.

Read more »

Two boys lie in the grass arm wrestling.
Healthcare Shares

Is CSL or Sonic Healthcare the smarter ASX healthcare share buy?

This ASX heavyweight has potential to deliver superior returns but is more volatile.

Read more »